Citriodiol in insect repellent may protect against COVID-19: UK study


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Citriodiol in insect repellent may protect against COVID-19: UK study
Citriodiol had anti-viral properties if mixed with the virus in the liquid phase and on a test surface

Citriodiol, an ingredient found in insect repellant, may kill novel coronavirus, according to British researchers. The ingredient extrapolated from the eucalyptus citriodora tree was studied for its use as a protective layer against SARS-CoV-2 by the UK’s military, according to a release by the Ministry of Defense.

The team of researchers out of the UK’s Defence Science and Technology Laboratory (Dstl) investigated the antiviral properties of Citriodiol against coronavirus by using a mosquito repellant, Mosi-guard, which contains Citriodiol as an active ingredient, the release stated. The insect repellant was applied to a liquid drop of the virus and then to a synthetic skin made of latex.

Citriodiol, an ingredient found in insect repellant, may kill the novel coronavirus, according to British researchers. (iStock)“One minute liquid suspension tests indicated that Mosi-guard Natural has anti-viral activity against SARS-CoV-2  isolate if mixed with the virus in the liquid phase. Additionally, viral studies on latex indicated that Mosi-guard Natural had antiviral activity against SARS-CoV-2 England-2 isolate," the UK report stated.

Back in May, UK Defense Secretary Ben Wallace confirmed that the British Armed Forces were using the insect repellant on a precautionary level as another potential layer of protection against the novel coronavirus, which was based on the advice of the UK surgeon general, who said it was unlikely to be harmful, according to an article in Science Focus.

“We are very excited by these findings and have several new studies either already going through laboratories or planned," Jacqueline Watson, managing director of Cetrifine, which produces Citriodiol, stated in a release on the company’s website.

The researchers stated in the report that “this research paper demonstrates preliminary findings on the effectiveness of Citriodiol against COVID-19.”

Dstl is hopeful that the findings in this research can be used as a springboard for other organizations to expand and develop the research, as well as to confirm the findings in this publication," the study authors added.

Citriodiol is approved by the U.S. Environmental Protection Agency (EPA) and recommended by the U.S. Centers for Disease Control and Prevention (CDC) for use against mosquito bites, which can ultimately help to prevent the spread of mosquito-borne diseases.

Tags : #Citriodol #Antiviral #UKStudy #LatestCovidNewsUpdateAug29 #EPA #DSTL #CDC #BenWallace

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026